HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 179 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $814,000 | +425.2% | 62,753 | +299.1% | 0.03% | +575.0% |
| Q4 2016 | $155,000 | -86.4% | 15,725 | -76.1% | 0.00% | -66.7% |
| Q4 2015 | $1,142,000 | +28.3% | 65,875 | -0.6% | 0.01% | +50.0% |
| Q3 2015 | $890,000 | +51.1% | 66,275 | +154.2% | 0.01% | +60.0% |
| Q2 2015 | $589,000 | +58.3% | 26,075 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $372,000 | +91.8% | 26,075 | +29.9% | 0.00% | +300.0% |
| Q4 2014 | $194,000 | -51.9% | 20,075 | -54.7% | 0.00% | -50.0% |
| Q3 2014 | $403,000 | -47.3% | 44,290 | -42.7% | 0.00% | -33.3% |
| Q2 2014 | $765,000 | -30.6% | 77,358 | -10.8% | 0.00% | -50.0% |
| Q1 2014 | $1,102,000 | -36.7% | 86,700 | -25.3% | 0.01% | -33.3% |
| Q4 2013 | $1,740,000 | – | 116,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |